臨床泌尿器科64巻8号

2010年07月発行

綜説

男性の尿失禁

著者： 朝倉博孝¹

所属機関： ¹埼玉医科大学病院泌尿器科

ページ範囲：P.535 - P.544

文献概要

要旨　本邦の尿失禁の頻度は，男性17.6％，女性43.9％と圧倒的に女性に多い。そして，腹圧性尿失禁の頻度は，男性2.7％，女性22.4％である。男性の腹圧性尿失禁は，頻度は低いものの難治性である。男性の腹圧性尿失禁は，良性・悪性疾患を問わず，圧倒的に前立腺摘出後，すなわち，医原性のものが多い。その他，男性の腹圧性尿失禁の原因は，放射線療法，神経因性膀胱，外傷などである。腹圧性尿失禁の標準治療は，人工括約筋埋没術である。しかし，普及していないのが問題である。その他の治療としては，膨張薬剤注入療法，スリング手術がある。切迫性尿失禁を呈する難治性排尿筋過活動の治療は，電気治療，磁気療法，ボツリヌス毒素などがあるが，未解決の問題も多い。

参考文献

1）本間之夫，柿崎秀宏，後藤百万，他：排尿に関する疫学的研究．日本排尿機能学会誌 14：266-277，2003

2）Arai Y, Kaiho Y, Takei M, et al：Burden of male stress urinary incontinence：a survey among urologists in Japan. Int J Urol 16：915-917, 2009

3）Malone-Lee JG：New data on urodynamics in the symptomatic elderly. Neurourol Urodyn 9：409, 1990

4）Kuo HC：Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions. J Urol 170：835-839, 2003

5）Schmid DM, Roy S, Sulsert T, et al：Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivty. BJU Int 102（Supl1）：7-10, 2008

6）Wyndaele JJ and Van Dromme SA：Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity. Spinal Cord 40：599-600, 2002

7）Sahai A, Khan MS and Dasgupta P：Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity：results from a single center, randomized, double-blind, placebo controlled trial. J Urol 177：2231-2236, 2007

8）Giannantoni A, Di Stasi SM, Stephen RL, et al：Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity：a prospective randomized study. J Urol 172：240-243, 2004

9）Kalsi V, Popat RB, Apostolidis A, et al：Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre. Eur Urol 49：519-527, 2006

10）Karsenty G, Elzayat E, Delapparent T, et al：Botulinum toxin type A injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux. J Urol 177：1011-1014, 2007

11）Smith CP, Radziszewski P, Borkowski A, et al：Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology 64：871-875, 2004

12）Apostolidis A, Dasgupta P and Fowler CJ：Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49：644-650, 2006

13）Tanagho E：Concepts of neuromodulation. Neurourol Urodyn 12：487-488, 1993

14）Primus G and Kramer G：Maximal external electrical stimulation for treatment of neurogenic or nonneurogenic urgency and/or urge incontinence. Neurourol Urodyn 15：187-194, 1996

15）Siegel SW, Richardson DA, Miller KL, et al：Pelvic floor electrical stimulation for the treatment of urge and mixed urinary incontinence in women. Urology 50：934-940, 1997

16）Dijkema HE, Weil EH, Mijs PT, et al：Neuromodulation of sacral nerves for incontinence and voiding dysfunctions：clinical results and complications. Eur Urol 24：72-76, 1993

17）Schmidt RA：Treatment of unstable bladder. Urology 37：28-32, 1991

18）Leng WW and Chancellor MB：How sacral nerve stimulation neuromodulation works. Urol Clin North Am 32：11-18, 2005

19）Keppene V, Mozer P, Chartier-Kastler E, et al：Neuromodulation in the management of neurogenic lower urinary tract dysfunction. Prog Urol 17：609-615, 2007

20）Bosch JL and Groen J：Disappointing results of neuromodulation in men with urge incontinence due to detrusor instability. Neurourol Urodyn 16：347-349, 1997

21）van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, et al：Results of sacral neuromodulation therapy for urinary voiding dysfunction：outcomes of a prospective, worldwide clinical study. J Urol 178：2029-2034, 2007

22）Kumar SP and Abrams PH：Detrusor myectomy：long-term results with a minimum follow-up of 2 years. BJU Int 96：341-344, 2005

23）Reyblat P and Ginsberg DA：Augmentation cystoplasty：what are the indications? Curr Urol Rep 9：452-458, 2008

24）Imamura T, Kinebuchi Y, Ishizuka O, et al：Implanteed mouse bone marrow-derived cells reconstruct layered smooth muscle structures in injured urinary bladders. Cell Transplant 17：267-278, 2008

25）Penson DF, McLerran D, Feng Z, et al：5-year urinary and sexual outcomes after radical prostatectomy：results from the prostate cancer outcomes study. J Urol 173：1701-1705, 2005

26）Begg CB, Riedel ER, Bach PB, et al：Variations in morbidity after radical prostatectomy. N Engl J Med 346：1138-1144, 2002

27）Coakley FV, Eberhardt S, Kattan MW, et al：Urinary continence after radical retropubic prostatectomy：relationship with membranous urethral length on preoperative endorectal magnetic resonance imaging. J Urol 168：1032-1035, 2002

28）Khan Z, Mieza M, Starer P, et al：Post-prostatectomy incontinence：a urodynamic and fluoroscopic point of view. Urology 38：483-488, 1991

29）Strasser H, Frauscher F, Helweg G, et al：Transurethral ultrasound：evaluation of anatomy and function of the rhabdosphincter of the male urethra. J Urol 159：100-104, 1998

30）Catalona WJ, Carvalhal GF, Mager DE, et al：Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol 162：433-438, 1999

31）Srougi M, Nesrallah LJ, Kauffmann JR, et al：Urinary continence and pathological outcome after bladder neck preservation during radical retropubic prostatectomy：a randomized prospective trial. J Urol 165：815-818, 2001

32）Burkhard FC, Kessler TM, Fleischmann A, et al：Nerve sparing open radical retropubic prostatectomy：does it have an impact on urinary continence? J Urol 176：189-195, 2006

33）Harris MJ：Radical perineal prostatectomy：cost efficient, outcome effective, minimally invasive prostate cancer management. Eur Urol 44：303-308, 2003

34）Groutz A, Blaivas JG, Chaikin DC, et al：The pathophysiology of post-radical prostatectomy incontinence：a clinical and video urodynamic study. J Urol 163：1767-1770, 2000

35）Giannantoni A, Mearini E, Di Stasi SM, et al：Assessment of bladder and urethral sphincter function before and after radical retropubic prostatectomy. J Urol 171：1563-1566, 2004

36）Bader P, Hugonnet CL, Burkhard FC, et al：Inefficient urethral milking secondary to urethral dysfunction as an additional risk factor for incontinence after radical prostatectomy. JUrol 166：2247-2252, 2001

37）John H, Sullivan MP, Bangerter U, et al：Effect of radical prostatectomy on sensory threshold and pressure transmission. J Urol 163：1761-1766, 2000

38）Wei JT, Dunn RL, Marcovich R, et al：Prospective assessment of patient reported urinary continence after radical prostatectomy. J Urol 164：744-748, 2000

39）Comiter CV, Sullivan MP and Yalla SV：Correlation among maximal urethral closure pressure, retrograde leak point pressure, and abdominal leak point pressure in men with postprostatectomy stress incontinence. Urology 62：75-78, 2003

40）Van Kampen M, De Weerdt W, Van Poppel H, et al：Effect of pelvic-floor re-education on duration and degree of incontinence after radical prostatectomy：a randomised controlled trial. Lancet 355：98-102, 2000

41）Lepor H and Kaci L：The impact of open radical retropubic prostatectomy on continence and lower urinary tract symptoms：a prospective assessment using validated self-administered outcome instruments. J Urol 171：1216-1219, 2004

42）McGuire EJ and Appell RA：Transurethral collagen injection for urinary incontinence. Urology 43：413-415, 1994

43）Tiguert R, Gheiler EL and Gudziak MR：Collagen injection in the management of post-radical prostatectomy intrinsic sphincteric deficiency. Neurourol Urodyn 18：653-658, 1999

44）Aboseif SR, O'Connell HE, Usui A, et al：Collagen injection for intrinsic sphincteric deficiency in men. J Urol 155：10-13, 1996

45）Smith DN, Appell RA, Rackley RR, et al：Collagen injection therapy for post-prostatectomy incontinence. J Urol 160：364-367, 1998

46）Cespedes RD, Leng WW and McGuire EJ：Collagen injection therapy for postprostatectomy incontinence. Urology 54：597-602, 1999

47）Gomes CM, Broderick GA, Sanchez-Ortiz RF, et al：Artificial urinary sphincter for post-prostatectomy incontinence：impact of prior collagen injection on cost and clinical outcome. J Urol 163：87-90, 2000

48）Comiter CV：The male sling for stress urinary incontinence：a prospective study. J Urol 167：597-601, 2002

49）Schneider T, Sperling H, Rossi R, et al：Do early injections of bulking agents following radical prostatectomy improve early continence? World J Urol 23：338-342, 2005

myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle rapir. Ann N Y Acad Sci 1776：135-143, 2009

51）Kielb SJ and Clemens JQ：Comprehensive urodynamics evaluation of 146 men with incontinence after radical prostatectomy. Urology 66：392-396, 2005

52）Stern JA, Clemens JQ, Tiplitsky SI, et al：Long-term results of the bulbourethral sling procedure. J Urol 173：1654-1656, 2005

53）Migliari R, Pistolesi D and De Angelis M：Polypropilene sling of the bulbar urethra for post-radical prostatectomy incontinence. Eur Urol 43：152-157, 2003

54）Madjar S, Jacoby K, Giberti C, et al：Bone anchored sling for the treatment of post-prostatectomy incontinence. J Urol 165：72-76, 2001

55）Ullrich NF and Comiter CV：The male sling for stress urinary incontinence：urodynamic and subjective assessment. J Urol 172：204-206, 2004

56）Onur R, Rajpurkar A and Singla A：New perineal bone-anchored male sling：lessons learned. Urology 64：58-61, 2004

57）Rajpurkar AD, Onur R and Singla A：Patient satisfaction and clinical efficacy of the new perineal bone-anchored male sling. Eur Urol 47：237-242, 2005

58）Giberti C, Gallo F, Schenone M, et al：The bone anchor sub-urethral sling for the treatment of iatrogenic male incontinence：subjective and objective assessment after 41 months of mean follow-up. World J Urol 26：173-178, 2008

59）Rehder P and Gozzi C：Transobturator sling suspension for male urinary incontinence including post-radical prostatectomy. Eur Urol 52：860-866, 2007

sling placement in the treatment of post-prostatectomy urinary incontinence. Int Braz J Urol 33：231-235, 2007

61）Cornel EB, Elzevier HW, Putter H, et al：Can advance transobturator sling suspension cure male urinary postoperative stress incontinence? J Urol, 183：1459-1463, 2010

62）Fischer MC, Huckabay C and Nitti VW：The male perineal sling：assessment and prediction of outcome. J Urol 177：1414-1418, 2007

63）Comiter CV：The male perineal sling：intermediate-term results. Neurourol Urodyn 24：648-653, 2005

64）Castle EP, Andrews PE, Itano N, et al：The male sling for post-prostatectomy incontinence：mean follow-up of 18 months. J Urol 173：1657-1660, 2005

65）Rajpurkar AD, Onur R and Singla A：Patient satisfaction and clinical efficacy of the new perineal bone-anchored male sling. Eur Urol 47：237-242, 2005

66）Suburethral synthetic sling insertion for stress urinary incontinence in men. National Institute for Health and Clinical Excellence. Available at：http://www.nice.org.uk/

67）Peréz LM and Webster GD：Successful outcome of artificial urinary sphincters in men with post-prostatectomy urinary incontinence despite adverse implantation features. J Urol 148：1166-1170, 1992

68）Gomha MA and Boone TB：Artificial urinary sphincter for post-prostatectomy incontinence in men who had prior radiotherapy：a risk and outcome analysis. J Urol 167：591-596, 2002

69）Haab F, Trockman BA, Zimmern PE, et al：Quality of life and continence assessment of the artificial urinary sphincter in men with minimum 3.5 years of follow-up. J Urol 158：435-439, 1997

70）Litwiller SE, Kim KB, Fone PD, et al：Post-prostatectomy incontinence and the artificial urinary sphincter：a long-term study of patient satisfaction and criteria for success. J Urol 156：1975-1980, 1996

71）Lai HH, Hsu EI, Teh BS, et al：13 years of experience with artificial urinary sphincter implantation at Baylor College of Medicine. J Urol 177：1021-1025, 2007

72）Fulford SC, Sutton C, Bales G, et al：The fate of the“modern”artificial urinary sphincter with a follow-up of more than 10 years. Br J Urol 79：713-716, 1997

73）DiMarco DS and Elliott DS：Tandem cuff artificial urinary sphincter as a salvage procedure following failed primary sphincter placement for the treatment of postprostatectomy incontinence. J Urol 170：1252-1254, 2003

74）Guralnick ML, Miller E, Toh KL, et al：Transcorporal artificial urinary sphincter cuff placement in cases requiring revision for erosion and urethral atrophy. J Urol 167：2075-2078, 2002

75）Lawton CA, Won M, Pilepich MV, et al：Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate：analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys 21：935-939, 1991

76）Sandhu AS, Zelefsky MJ, Lee HJ, et al：Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection. Int J Radiat Oncol Biol Phys 48：643-647, 2000

stereotactic dose-escalated radiotherapy of prostate cancer. Radiother Oncol 63：239-248, 2002

78）Jonler M, Ritter MA, Brinkmann R, et al：Sequelae of definitive radiation therapy for prostate cancer localized to the pelvis. Urology 44：876-882, 1994

79）Petrovich Z, Lieskovsky G, Langholz B, et al：Comparison of outcomes of radical prostatectomy with and without adjuvant pelvic irradiation in patients with pathologic stage C（T3N0）adenocarcinoma of the prostate. Am J Clin Oncol 22：323-331, 1999

80）Petroski RA, Warlick WB, Herring J, et al：External beam radiation therapy after radical prostatectomy：efficacy and impact on urinary continence. Prostate Cancer Prostatic Dis 7：170-177, 2004

81）Rogers E, Ohori M, Kassabian VS, et al：Salvage radical prostatectomy：outcome measured by serum prostate specific antigen levels. J Urol 153：104-110, 1995

82）Martins FE, Bennett CJ, DunnM, et al：Adverse prognostic features of collagen injection therapy for urinary incontinence following radical retropubic prostatectomy. J Urol 158：1745-1749, 1997

83）Martins FE and Boyd SD：Artificial urinary sphincter in patients following major pelvic surgery and/or radiotherapy：are they less favorable candidates? J Urol 153：1188-1193, 1995

84）Gundian JC, Barrett DM and Parulkar BG：Mayo Clinic experience with the AS800 artificial urinary sphincter for urinary incontinence after transurethral resection of prostate or open prostatectomy. Urology 41：318-321, 1993

85）Cummings JM, Boullier JA and Parra RO：Transurethral collagen injections in the therapy of post-radical prostatectomy stress incontinence. J Urol 155：1011-1013, 1996

86）Elsergany R and Ghoniem GM：Collagen injection for intrinsic sphincteric deficiency in men：a reasonable option in selected patients. J Urol 159：1504-1506, 1998

87）Westney OL, Bevan-Thomas R, Palmer JL, et al：Transurethral collagen injections for male intrinsic sphincter deficiency：the University of Texas-Houston experience. J Urol 174：994-997, 2005

88）Comiter CV：The male sling for stress urinary incontinence：a prospective study. J Urol 167：597-601, 2002

89）Schaeffer AJ, Clemens JQ, Ferrari M, et al：The male bulbourethral sling procedure for post-radical prostatectomy incontinence. J Urol 159：1510-1515, 1998

90）Wallner K, Roy J, Zelefsky M, et al：Fluoroscopic visualization of the prostatic urethra to guide transperineal prostate implantation. Int J Radiat Oncol Biol Phys 29：863-867, 1994

91）Benoit RM, Naslund MJ and Cohen JK：Complications after prostate brachytherapy in the medicare population. Urology 55：91-96, 2000

92）Crook J, Lukka H, Klotz L, et al：Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer. CMAJ 164：975-981, 2001

93）Petit JH, Gluck C, Kiger WS 3rd, et al：Androgen deprivation-mediated cytoreduction before interstitial brachytherapy for prostate cancer does not abrogate the elevated risk of urinary morbidity associated with larger initial prostate volume. Brachytherapy 6：267-271, 2007

94）Hu K and Wallner K：Urinary incontinence in patients who have a TURP/TUIP following prostate brachytherapy. Int J Radiat Oncol Biol Phys 40：783-786, 1998

95）Grills IS, Martinez AA, Hollander M, et al：High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol 171：1098-1104, 2004

96）Nguyen PL, D'Amico AV, Lee AK, et al：Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure：a systematic review of the literature. Cancer 110：1417-1428, 2007

97）Rebillard X, Soulie M, Chartier-Kastler E, et al：High intensity focused ultrasound in prostate cancer；a systematic literature review of the French Association of Urology. BJU Int 101：1205-1213, 2008

98）Herschorn S, Boccon-Gibod L, Bosch JL, et al：Surgical treatment of urinary incontinence in men. In：First International Consultation on Urinary Incontinence. edited by Abrams P, Khoury S and Wein A. Health Publications Ltd. Plymouth, pp691-729, 1999

99）Tan A, Liao C, Mo Z, et al：Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. Br J Surg 94：1201-1208, 2007

100）Montorsi F, Naspro R, Salonia A, et al：Holmium laser enucleation versus transurethral resection of the prostate：results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 172：1926-1929, 2004

101）Scott FB：The artificial urinary sphincter：experience in adults. Urol Clin North Am 16：105, 1989

102）Wilson SK, Delk JR 2nd, Henry GD, et al：New surgical technique for sphincter urinary control system using upper transverse scrotal incision. J Urol 169：261-264, 2003

103）Godbole P and Mackinnon AE：Expanded PTFE bladder neck slings for incontinence in children：the long-term outcome. BJU Int 93：139-141, 2004

104）Herschorn S, Thijssen A and Radomski SB：The value of immediate or early catheterization of the traumatized posterior urethra. J Uro 148：1428-1431, 1992

105）Kotkin L and Koch MO：Impotence and incontinence after immediate realignment of posterior urethral trauma：result of injury or management? J Urol 155：1600-1603, 1996